Recent Updates
Recently added Catalysts
ELDN Neutral Sentiment

Transplanting Islet Cells with Piotr Witkowski, MD, PhD

Key Takeaway: The article discusses the work of Dr. Piotr Witkowski in transplanting islet cells, highlighting the transformative impact on patients' lives. It provides an overview of the clinical trials and mechanisms involved in this innovative approach. The piece emphasizes the importance of ongoing research and patient stories in understanding the benefits of islet cell transplantation.
Price reaction · baseline $3.16 (2026-04-14T17:52:00.000Z) · hit during market hours · clean, no other ELDN news in the window
day 0 close · peak
+1.3%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+90%
120-day peak, hindsight
Typical move
6.5%
average across 7 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
AT-1501
Phase 2 · Kidney Transplant Rejection

Full Press Release Details

Transforming Lives. One Organ at a Time.
• Overview Focus Patient Stories Clinical Trials In The News
• Science Mechanism of Action Pipeline Publications & Presentations In The News
• Team Overview Leadership Board of Directors
• Investors Overview News & Events Press Releases Events Publications & Presentations Corporate Governance Governance Overview Committee Composition Ethics Hotline Financials SEC Filings Stock Information Stock Quote & Chart Analyst Coverage Resources Investor FAQs Email Alerts Contact IR
• Culture/Careers Culture Careers
• Contact
• Focus
• Patient Stories
• Clinical Trials
• In The News
• Mechanism of Action
• Pipeline
• Publications & Presentations
• In The News
• Overview
• Leadership
• Board of Directors
• Overview
• News & Events Press Releases Events Publications & Presentations
• Corporate Governance Governance Overview Committee Composition Ethics Hotline
• Financials SEC Filings
• Stock Information Stock Quote & Chart Analyst Coverage
• Resources Investor FAQs Email Alerts Contact IR
• Press Releases
• Events
• Publications & Presentations
• Governance Overview
• Committee Composition
• Ethics Hotline
• SEC Filings
• Stock Quote & Chart
• Analyst Coverage
• Investor FAQs
• Email Alerts
• Contact IR
• Culture
• Careers
• Privacy Overview
• Necessary
• Analytics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.

Frequently Asked Questions

What is islet cell transplantation?

Islet cell transplantation involves transplanting insulin-producing cells from a donor pancreas into a patient.

Who is Dr. Piotr Witkowski?

Dr. Piotr Witkowski is a medical professional specializing in islet cell transplantation.

What are the benefits of islet cell transplantation?

Islet cell transplantation can significantly improve the quality of life for patients with diabetes.

What role do clinical trials play?

Clinical trials are essential for advancing research and understanding the efficacy of islet cell transplantation.

Last updated: Apr 14, 2026